COLL vs LI · P/E 17, rev $181.9M vs P/E 24, rev $16.06B
Collegium Pharmaceutical Inc (COLL) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the COLL and LI stock pages for the full models.
Not investment advice.